St. Jude Medical Highlights Leading Technologies and Physician Training at Cardiac Arrhythmia Congresses in Japan
September 16 2011 - 2:02AM
Business Wire
St. Jude Medical, Inc. (NYSE:STJ), a global medical device
company, is pleased to again participate in the Asia-Pacific Heart
Rhythm Society Scientific Session (APHRS), which is being held this
year in conjunction with the Japanese Heart Rhythm Society (JHRS)
and the Japanese Society of Electrocardiology (JSE) in Fukuoka,
Japan.
The clinical solutions from the company’s arrhythmia management
portfolio are some of the most technologically advanced therapies
and devices in Asian markets. Additionally, the sponsored symposia
and virtual reality technology highlight the company’s commitment
to providing a comprehensive learning platform for physicians.
Commenting on the company’s presence at APHRS, William Phillips,
president of St. Jude Medical Japan said, “St. Jude Medical is
pleased to once again be one of the largest sponsors of the annual
APHRS congress, and to help support the advancement of the practice
of medicine with physicians throughout Asia. We continue to invest
in Japan and the Asia Pacific region by broadening our product
portfolio and investing in ongoing education with our advanced
technology centers to help physicians develop the knowledge and
skill needed to enhance patient care.”
Focus on Physician Education
St. Jude Medical regularly partners with societies, institutions
and physicians to help drive continuous learning. The company
recently partnered with APHRS to help with the design and to lead
courses at one of the company’s Advanced Technology Centers, which
opened in Beijing earlier this year. The courses provide realistic,
hands-on experiences for physicians who help treat cardiac-related
illnesses. The company plans to open a new Advanced Technology
Center in Tokyo in 2012.
A virtual reality simulator from the company’s Advanced
Technology Center will again be accessible at the St. Jude Medical
innovation suite. Designed to help enhance patient care, the
hands-on simulator offers physicians access to advanced cardiac
care techniques and best clinical practices using the latest St.
Jude Medical technology to simulate procedures, such as implanting
a left ventricular (LV) lead or performing a transseptal puncture.
From guiding catheters through the vessels, to optimally placing a
lead in a human-size model, the unique experiences from the virtual
reality technology help enhance physician education.
In addition, St. Jude Medical has sponsored several scientific
symposia including:
- Remote Disease
Management: This symposium takes place Sept. 20 at 12 p.m.
in Room C. It addresses future diagnostic uses for remote
monitoring and early experiences for Asia patients, and is chaired
by Dr. Chun Chieh Wang.
- Effective
Technologies and Approaches for AF Management: This
symposium takes place Sept. 21 at 12 p.m. in Room J. It focuses on
streamlining cardiac mapping and improving outcomes with the latest
ablation technologies, and is jointly chaired by Prof. Young Hoon
Kim and Prof. Shih Ann Chen.
- Advanced Heart
Failure Management with Quadripolar Technology: This
symposium takes place Sept. 22 at 12 p.m. in Room D. It provides
information about how quadripolar technology offers more options to
manage pacing complications and is hosted by Dr. Anil Saxena.
Arrhythmia Management Products on Display
Products and technologies will be on display at the St. Jude
Medical booth during exhibit hall hours. For additional information
about the products displayed in the St. Jude Medical booth, please
visit sjm.com.
- Unify™ CRT-D and Fortify™ ST ICD: The
Unify cardiac resynchronization therapy defibrillator (CRT-D) and
Fortify implantable cardioverter defibrillator (ICD) is a new
family of devices that feature advanced battery technology and
circuitry that allow for the smallest device footprint in the
industry and rapid charge times, without any compromise in device
longevity or power. Because of the devices' narrower shape,
physicians can implant them using a shorter incision, leading to
less time spent closing the incision and a smaller scar for the
patient. The technologies also incorporate the company’s
first-to-market ST segment monitoring diagnostic algorithm
(available in Fortify ST ICD) that continuously monitors for
specific changes in the ST segment of the electrocardiogram that
can indicate the onset of serious conditions such as ischemia
(which occurs when blood flow/oxygen to the heart muscle is
obstructed). The Unify CRT-D and Fortify ICD are approved for use
in the U.S., Japan, Europe, Australia, New Zealand, India, Taiwan,
Korea, Malaysia, and Hong Kong, among other geographies.
- Accent™ RF Pacemaker and Anthem™ RF
CRT-P: The Accent and Anthem product family features RF telemetry
that enables secure, wireless communication between the implanted
device and the programmer used by the physician or clinician,
making it the first integrated system of pacing devices with
wireless telemetry from implant through follow-up. The remote
monitoring capabilities permit automated follow-up, and daily
device safety checks with no patient action required. The products
are approved for use in the U.S., Japan, Europe, China, Australia,
New Zealand, India, Taiwan, Korea, Malaysia, and Hong Kong, among
other geographies.
- EnSite Velocity™ Cardiac Mapping
System: The next-generation of the industry-leading EnSite™ System
is designed to help physicians more efficiently diagnose abnormal
heart rhythms. The EnSite Velocity System creates a
three-dimensional (3-D) model of the patient's heart, allowing
physicians to visualize their patient's unique anatomy with great
detail. Physicians can then quickly locate the source of the
arrhythmia and formulate a treatment strategy. It is the only
cardiac mapping system that is compatible with both contact mapping
(NavX) and non-contact mapping (Array) technologies. The new
platform is customizable, providing the flexibility to better
integrate current and future technology. The EnSite Velocity is
approved for use in the U.S., Europe, China, Japan, Australia,
Korea, India, Hong Kong, Singapore, Thailand, and Malaysia, among
other geographies.
- Other products on display include the
EP-Workmate™ Recording System, Agilis NxT™ Steerable Introducer,
the Cool Point™ Irrigation Pump, among others.
About APHRS
APHRS is the first and only society organized in the
Asia-Pacific region to promote excellence and advancement in the
diagnosis and treatment of the patients with heart rhythm
disorders. Its objectives include providing opportunities for
exchanging scientific, medical and technological information among
its members and with members of other national/international
organizations by hosting annual APHRS scientific sessions and other
related symposia.
About St. Jude Medical
St. Jude Medical develops medical technology and services that
focus on putting more control into the hands of those who treat
cardiac, neurological and chronic pain patients worldwide. The
company is dedicated to advancing the practice of medicine by
reducing risk wherever possible and contributing to successful
outcomes for every patient. St. Jude Medical is headquartered in
St. Paul, Minn. and has four major focus areas that include:
cardiac rhythm management, atrial fibrillation, cardiovascular and
neuromodulation. For more information, please visit sjm.com.
Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties. Such forward-looking
statements include the expectations, plans and prospects for the
Company, including potential clinical successes, anticipated
regulatory approvals and future product launches, and projected
revenues, margins, earnings and market shares. The statements made
by the Company are based upon management’s current expectations and
are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include
market conditions and other factors beyond the Company’s control
and the risk factors and other cautionary statements described in
the Company’s filings with the SEC, including those described in
the Risk Factors and Cautionary Statements sections of the
Company’s Annual Report on Form 10-K for the fiscal year ended
January 1, 2011 and Quarterly Report on Form 10-Q for the fiscal
quarter ended July 2, 2011. The Company does not intend to update
these statements and undertakes no duty to any person to provide
any such update under any circumstance.
SJM (NYSE:STJ)
Historical Stock Chart
From Jun 2024 to Jul 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Jul 2023 to Jul 2024